Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Wajd Alkabbani, Ph.D.

Concepts (66)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dipeptidyl-Peptidase IV Inhibitors520232933.110 Why?
Diabetes Mellitus, Type 2152023117342.270 Why?
Symporters320233592.070 Why?
Muscular Diseases320235501.860 Why?
Hypoglycemia320238621.610 Why?
Dementia6202325211.500 Why?
Sodium9202316071.300 Why?
Diabetic Ketoacidosis220222471.270 Why?
Hypoglycemic Agents11202328911.170 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors3202332650.890 Why?
Glucose9202343670.810 Why?
Thiazolidinediones120214750.640 Why?
Glucosides120214510.600 Why?
Cannabinoids120191650.580 Why?
Thiophenes120215870.570 Why?
Sulfonylurea Compounds320222050.550 Why?
Urinary Tract Infections120217860.520 Why?
Alberta32023620.480 Why?
Drug Interactions3202314490.460 Why?
Sodium-Glucose Transporter 222023850.420 Why?
Prescription Drugs120195950.420 Why?
Insulin5202365830.380 Why?
Cohort Studies82023405450.350 Why?
Acute Kidney Injury1202218730.350 Why?
Medication Adherence1201920750.300 Why?
Physicians1202245650.240 Why?
British Columbia120232430.220 Why?
Manitoba12019230.180 Why?
Glucagon-Like Peptide 1120213390.170 Why?
Humans1920237435210.170 Why?
Adverse Drug Reaction Reporting Systems120224700.160 Why?
Cannabidiol120191050.150 Why?
Propensity Score1202117800.130 Why?
Fibromyalgia120193880.120 Why?
Randomized Controlled Trials as Topic2202199670.120 Why?
Drug Combinations1201919600.120 Why?
Osteoarthritis1201910390.100 Why?
Risk Factors32023723250.100 Why?
Social Class1201919960.090 Why?
Antipsychotic Agents1202330570.090 Why?
Chronic Disease1202291620.070 Why?
Blood Glucose1202162630.070 Why?
Research Design1202160000.060 Why?
Middle Aged320232131850.060 Why?
Reproducibility of Results12021198470.060 Why?
Substance-Related Disorders1201942500.050 Why?
Retrospective Studies22023774570.050 Why?
Hospitalization12021102720.050 Why?
Aged, 80 and over22023577390.050 Why?
Aged220231631370.040 Why?
Psychotropic Drugs120238930.040 Why?
Benzodiazepines1202311020.040 Why?
Adult220232138700.040 Why?
Nursing Homes1202310370.030 Why?
Male320233497710.030 Why?
Female320233798750.030 Why?
Anticonvulsants1202319060.030 Why?
Young Adult12019564100.030 Why?
Antidepressive Agents1202328400.020 Why?
Adolescent12019857570.020 Why?
Risk1202396800.020 Why?
Neoplasms12019216700.020 Why?
Animals120211684340.020 Why?
Analgesics, Opioid1202336670.020 Why?
Pandemics1202383850.010 Why?
Cross-Sectional Studies12023250580.010 Why?
Alkabbani's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (66)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.